Mukai H, Watanabe S, Morino A
Research Laboratories, Nippon Shinyaku Co., Ltd., Kyoto, Japan.
Arzneimittelforschung. 1999 Jun;49(6):527-32. doi: 10.1055/s-0031-1300455.
The absorption and excretion of NS-49 ((R)-(-)-3'-(2-amino-1-hydroxyethyl)-4'-fluoromethanesulfonanilide hydrochloride, CAS 137431-04-0), a phenethylamine class alpha 1A-adrenoceptor agonist, were studied in male rabbits, dogs, and monkeys after intravenous or oral administration of 14C-NS-49. After single oral administration of 14C-NS-49 (1 mg/kg) to rabbits and dogs, the plasma concentrations of radioactivity and NS-49 reached maximums at about 2 h, then decreased triexponentially. In monkeys, both maximums were reached 3 h after administration, and both concentrations decreased biexponentially. Most of the plasma radioactivity was due to unchanged NS-49 in the rabbits and dogs, indicating poor metabolism of this drug. In the monkeys, however, the percentage of unchanged NS-49 in the plasma radioactivity was low, about 20%, during a 24-h period after oral administration. After intravenous and oral administrations of 14C-NS-49, radioactivity was primarily excreted in the urine in all the species tested. The absorption rates found by comparing the urinary excretions of radioactivity after both routes of administration were 71% for rabbits, 92% for dogs, and 95% for monkeys. The percentages of NS-49 in the radioactivity excreted in the urine after intravenous and oral administrations, respectively, were 77% and 68% for rabbits, 96% and 96% for dogs, and 57% and 29% for monkeys. The systemic availability calculated from the unchanged drug excreted in the urine was similar to the absorption rates for rabbits and dogs. This indicates that first-pass metabolism of this drug is very limited in both species. The systemic availability for monkeys, however, was about half the absorption rate due to the first-pass effect. Renal clearance accounted for most of the total clearance for rabbits and dogs, but only about half that for monkeys.
研究了苯乙胺类α1A -肾上腺素能受体激动剂NS - 49((R)-(-)-3'-(2 -氨基-1 -羟乙基)-4'-氟甲磺酰苯胺盐酸盐,CAS 137431 - 04 - 0)在雄性兔、犬和猴静脉注射或口服14C - NS - 49后的吸收和排泄情况。给兔和犬单次口服14C - NS - 49(1mg/kg)后,放射性和NS - 49的血浆浓度在约2小时达到最大值,然后呈三指数下降。在猴中,给药后3小时达到两个最大值,且两种浓度均呈双指数下降。在兔和犬中,大部分血浆放射性是由于未变化的NS - 49,表明该药物代谢较差。然而,在猴中,口服给药后24小时内,血浆放射性中未变化的NS - 49百分比很低,约为20%。静脉注射和口服14C - NS - 49后,在所有受试物种中放射性主要经尿液排泄。通过比较两种给药途径后放射性的尿排泄量发现,兔的吸收速率为71%,犬为92%,猴为95%。静脉注射和口服给药后尿中排泄的放射性中NS - 49的百分比,兔分别为77%和68%,犬为96%和96%,猴为57%和29%。根据尿中排泄的未变化药物计算的全身可用性与兔和犬的吸收速率相似。这表明该药物在这两个物种中的首过代谢非常有限。然而,由于首过效应,猴的全身可用性约为吸收速率的一半。肾清除率占兔和犬总清除率的大部分,但仅约为猴的一半。